WHO seal: Covaxin may be missing the USFDA ballast

WHO experts to reconvene for final risk-benefit study on November 3

Comments

Popular posts from this blog

Viral video involving woman cop sparks controversy, plaint filed

Infosys lays off hundreds after failing internal assessments in Mysuru

Congress groomed me not to sit at home: Shivakumar